| Medications for Scleroderma, Arthritis,
Autoimmune and Rheumatic Diseases |
| This page was written by Janey Willis, and has not yet been medically edited. See Disclaimer. |
| |
| FDA Warnings and Voluntary Recalls on Medications and Treatments |
| Arthritis drugs raise cancer risk in kids-US FDA. The Food and Drug Administration, which urged greater caution with so-called TNF blockers last September, said an analysis of 48 reported cancer cases in children using the drugs "showed an increased risk of cancer, occurring after 30 months of treatment on average." Reuters. 08/04/09. (Also see: TNF Inhibitors) |
| FDA May Restrict Acetaminophen. Advisers Tell the Agency to Lower Over-the-Counter Dose of Popular Pain Drug saying the move would protect people from the potential toxicity that can cause liver failure and even death. Kathryn Foxhall WebMD Health News. July 1, 2009. |
| Psoriasis Drug Removed from Market, Mark & Associates, P.C. Offering Free Consultations for Raptiva Patients at www.RaptivaPML.Com. On April 8, 2009, Genentech announced that it was suspending sales of Raptiva in the U.S., due to reports of people taking the drug developing Progressive multifocal leukoencephalopathy or PML. The company advised physicians to immediately stop prescribing Raptiva for new psoriasis patients and to contact patients currently taking the drug to determine the best course of action for treatment. WebWire. 04/08/09. (Also see: Psoriasis) |
| FDA Puts Black-Box Warning on Bowel-Cleansing Drugs. The FDA said it would now require a black-box warning on the oral sodium phosphate products Visicol and OsmoPrep, alerting consumers about the risk of acute phosphate nephropathy -- a type of severe kidney injury. Washington Post. 12/11/08. (Also see: Bowel Dysfunction) |
| Govt pays for deadly, unapproved drugs. Dozens of deaths have been linked to medications that have never been reviewed by the government for safety and effectiveness but are still covered under Medicaid. Comcast.net News. 11/24/08. (Also see: Colchicine) |
| Psoriasis Drug Raptiva Gets FDA Warning. The psoriasis drug Raptiva is getting a "black box" warning, the FDA's sternest warning, about the risk of life-threatening infections including a rare brain infection and meningitis. WebMD. 10/16/08. (Also see: Psoriasis) |
| Mercury teeth fillings may harm some: U.S. FDA. Silver-colored metal dental fillings contain mercury that may cause health problems in pregnant women, children and fetuses. Reuters. 06/04/08. (Also see: Causes of Scleroderma) |
| Bisphosphonates Linked To Incapacitating Bone, Joint, and Muscle Pain - FDA Alerts The Food and Drug Administration (FDA) is reminding doctors of the link between taking bisphosphonates and a raised risk of experiencing often incapacitating bone, joint, and/or musculoskeletal pain. Medical News Today. 07 Jan 2008. (Also see: Osteoporosis) |
| Fentanyl Pain Patch Recalled. Voluntary Recall of Duragesic and Generic Fentanyl Patch Due to Overdose Risk. WebMD. 02/13/08. |
| Botox Linked To Respiratory Failure And Death, FDA Advises. The most severe adverse effects were found in children treated for spasticity in their limbs associated with cerebral palsy. ScienceDaily. 02/10/08. |
| FDA: Don't Use Quinine for Leg Cramps. FDA Cracks Down on Unapproved Quinine Drugs, Cites Problems Including Deaths. WebMD Medical News. 12/12/06. |
| FDA Issues Public Health Advisory on the Fentanyl (Duragesic) Patch in response to reports of deaths in patients using this potent narcotic medication for pain management. Medical News Today 07/18/05. |
| Scleroderma Clinical Trials and Open Enrollments Includes proven treatments, unproven, open enrollments, pending results, and research registries. ISN. |
